IPAR Q1 2026 Earnings Strong EPS Beat Highlights Robust Fragrance Demand Amid Market Challenges
STUB Q1 2026 Earnings Earnings Per Share Surges Past Estimates Revenue Not Reported
ZBIO Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Pipeline
CFFN Q1 2026 Earnings EPS Misses Estimates Amid Narrowing Net Interest Margin
BHC Q1 2026 Earnings EPS Beat of 1233 Amid Broader Market Concerns
Cyclerion Therapeutics CYCN Edges Higher as Shares Test Key Resistance Levels
AGNCN Preferred Stock Holds Steady Near 2574 Amid Narrow Trading Range
Wave Life Sciences WVE Holds Steady Near Key Support Amid Modest Decline
Alarum Technologies ALAR Holds Steady Near Support as Bulls Test Resistance
MPAA Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment